Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.” ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Explore how psychosocial and physical stress affects cfDNA release in blood and saliva. Discover gender differences and ...

"Further investigation of cfDNA-sequencing patterns would help to identify the subgroup of persons with nonreportable results who might have cancer." A cell-free DNA test, or cfDNA, is a test of ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening ... who initially received unusual or nonreportable clinical cfDNA-sequencing results, the IDENTIFY study showed.

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including molecular reference standards, today announces the launch of its first ...